Stephen Thomas's most recent trade in Climb Bio Inc. was a trade of 33,687 Common Stock done at an average price of $7.0 . Disclosure was reported to the exchange on Feb. 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Climb Bio Inc | Stephen Thomas | Director | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 25 Feb 2026 | 33,687 | 170,970 | - | 7.0 | 235,964 | Common Stock |
| Climb Bio Inc | Stephen Thomas | Director | Sale of securities on an exchange or to another person at price $ 7.01 per share. | 25 Feb 2026 | 16,313 | 154,657 | - | 7.0 | 114,289 | Common Stock |
| Climb Bio Inc | Stephen Thomas | Director | Sale of securities on an exchange or to another person at price $ 5.23 per share. | 12 Feb 2026 | 90,000 | 214,657 | - | 5.2 | 470,988 | Common Stock |
| Climb Bio Inc | Stephen Thomas | Director | Sale of securities on an exchange or to another person at price $ 5.81 per share. | 12 Feb 2026 | 10,000 | 204,657 | - | 5.8 | 58,141 | Common Stock |
| Blackrock Energy & Resources Trust | Stephen Thomas Minar | Vice President | Purchase of securities on an exchange or from another person at price $ 14.91 per share. | 10 Feb 2026 | 1,900 | 1,900 (0%) | 0% | 14.9 | 28,329 | Common Stock |
| Blackrock Energy & Resources Trust | Stephen Thomas Minar | Vice President | Purchase of securities on an exchange or from another person at price $ 14.91 per share. | 10 Feb 2026 | 1,300 | 3,200 (0%) | 0% | 14.9 | 19,383 | Common Stock |
| Blackrock Energy & Resources Trust | Stephen Thomas Minar | Vice President | Purchase of securities on an exchange or from another person at price $ 14.90 per share. | 10 Feb 2026 | 850 | 4,320 (0%) | 0% | 14.9 | 12,665 | Common Stock |
| BlackRock Science and Tech Trust II | Stephen Thomas Minar | Vice President | Purchase of securities on an exchange or from another person at price $ 23.15 per share. | 10 Feb 2026 | 600 | 8,687 (0%) | 0% | 23.2 | 13,890 | Common Stock |
| Blackrock Energy & Resources Trust | Stephen Thomas Minar | Vice President | Purchase of securities on an exchange or from another person at price $ 14.93 per share. | 10 Feb 2026 | 270 | 3,470 (0%) | 0% | 14.9 | 4,031 | Common Stock |
| BlackRock Science and Tech Trust II | Stephen Thomas Minar | Vice President | Purchase of securities on an exchange or from another person at price $ 23.15 per share. | 10 Feb 2026 | 140 | 8,827 (0%) | 0% | 23.2 | 3,241 | Common Stock |
| BlackRock Science and Tech Trust II | Stephen Thomas Minar | Vice President | Purchase of securities on an exchange or from another person at price $ 23.15 per share. | 10 Feb 2026 | 110 | 8,937 (0%) | 0% | 23.2 | 2,547 | Common Stock |
| BlackRock Science and Tech Trust II | Stephen Thomas Minar | Vice President | Purchase of securities on an exchange or from another person at price $ 23.13 per share. | 10 Feb 2026 | 15 | 8,074 (0%) | 0% | 23.1 | 347 | Common Stock |
| BlackRock Science and Tech Trust II | Stephen Thomas Minar | Vice President | Purchase of securities on an exchange or from another person at price $ 23.08 per share. | 10 Feb 2026 | 13 | 8,087 (0%) | 0% | 23.1 | 300 | Common Stock |
| Climb Bio Inc | Stephen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 100,375 | 304,657 | - | 0 | Common Stock | |
| Climb Bio Inc | Stephen Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2025 | 25,094 | 204,282 | - | - | Common Stock | |
| Climb Bio Inc | Stephen Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2025 | 25,094 | 0 | - | - | Restricted Stock Units | |
| Climb Bio Inc | Stephen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc | Stephen Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2025 | 25,093 | 179,188 | - | - | Common Stock | |
| Climb Bio Inc | Stephen Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2025 | 25,093 | 25,094 | - | - | Restricted Stock Units | |
| Climb Bio Inc | Stephen Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 50,188 | 154,095 | - | - | Common Stock | |
| Climb Bio Inc | Stephen Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 50,188 | 50,187 | - | - | Restricted Stock Units | |
| Climb Bio Inc | Stephen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 103,907 | 103,907 | - | - | Common Stock | |
| Climb Bio Inc | Stephen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 100,375 | 100,375 | - | - | Restricted Stock Units | |
| Gamida Cell | Thomas Wills Stephen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 200,000 | 256,177 | - | 0 | Ordinary Shares | |
| Gamida Cell | Stephen Thomas Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 56,600 | 56,600 | - | - | Share Option (Right to Buy) | |
| Gamida Cell | Stephen Thomas Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 28,300 | 41,977 | - | 0 | Ordinary Shares | |
| Gamida Cell | Stephen Thomas Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 28,300 | 28,300 | - | - | Share Option (Right to Buy) | |
| Gamida Cell | Stephen Thomas Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 14,200 | 56,177 | - | 0 | Ordinary Shares | |
| Gamida Cell | Stephen Thomas Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 9,500 | 9,500 | - | - | Share Option (Right to Buy) | |
| Gamida Cell | Stephen Thomas Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 2,000 | 13,677 | - | 0 | Ordinary Shares | |
| Gamida Cell | Stephen Thomas Wills | Director | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 30 Sep 2022 | 9,677 | 11,677 | - | 1.5 | 14,999 | Ordinary Shares |